Functional brain imaging using a long intravenous half-life gadolinium-based contrast agent

AJNR Am J Neuroradiol. 2006 Aug;27(7):1467-71.

Abstract

Purpose: We describe a technique for functional MR imaging (fMRI) with high spatial and temporal resolution using a long intravascular half-life gadolinium-based contrast agent, MS-325.

Methods: All fMRI measurements used a rat model of sensory cortex activation with forepaw electrical stimulation under alpha-chloralose anesthesia. Standard blood oxygen level-dependent (BOLD) fMRI measurement was initially performed. MS-325 was then intravenously administered and a MS-325 fMRI measurement was performed by using a 3D gradient-echo sequence.

Results: We found that a dose of 0.1 mmol/kg MS-325 produced adequate signal intensity changes in rat sensory cortex to demonstrate activations. Using a boxcar stimulation pattern with a standard correlation analysis, the locations of the most significantly activated voxels (ie, highest Z score) in the MS-325 and BOLD fMRI measurements were not significantly different.

Conclusions: MS-325 fMRI has the advantage of using a T1-weighted sequence, rather than the highly T2*-weighted sequences used in other common fMRI techniques. This could reduce the susceptibility artifacts associated with fMRI.

MeSH terms

  • Animals
  • Contrast Media / administration & dosage*
  • Electric Stimulation
  • Feasibility Studies
  • Foot / innervation
  • Gadolinium* / administration & dosage
  • Half-Life
  • Image Enhancement / methods
  • Imaging, Three-Dimensional / methods
  • Injections, Intravenous
  • Magnetic Resonance Imaging / methods*
  • Male
  • Organometallic Compounds* / administration & dosage
  • Rats
  • Rats, Sprague-Dawley
  • Somatosensory Cortex / physiology*

Substances

  • Contrast Media
  • Organometallic Compounds
  • Gadolinium
  • gadofosveset trisodium